Prolonged global demand weakness
Extended downcycle in global crop protection market due to low commodity prices and geopolitical uncertainties could delay recovery.
PI / bear-case history
Track the concerns that keep returning.
PI Industries · risk themes across the available quarters.
Research layer active
Bear-case history
Risks carried through the record.
high
Slow conversion of pharma and biologicals investments
Pharma and biologicals businesses are incurring quarterly losses of ₹75-80 crore, and breakeven may take longer than expected.
Working capital pressure
Trade working capital days increased sharply to 139 days, reflecting market conditions and partner support needs.
Regulatory hurdles in domestic biologicals
Regulatory issues in Indian biologicals market have impacted portfolio, though management expects resolution by Q4.